SCYNEXIS
SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant fungal infections.
Org chart
Discover similar companies
UNITY Biotechnology
Post IPO Debt • San Francisco, United States
Fortress Biotech
Post IPO Debt • New York, United States
Eiger BioPharmaceuticals
Post IPO Debt • Palo Alto, United States
New Age Meats
Series A • Berkeley, United States
Paradromics
Seed • San Jose, United States
Lantern Pharma
Post IPO Secondary • Dallas, United States
ECHO
Series A • San Diego, United States
Eastside Distilling
Post IPO Debt • Portland, United States
Ensysce Biosciences
Post IPO Debt • San Diego, United States
Travere Therapeutics
Post IPO Debt • San Diego, United States
PathSpot
Series A • New York, United States
HistoWiz
Series A • NY, United States
helps you hire
great candidates
It’s free to use - try it out today.